The National Health Surveillance Agency (ANVISA) issued important guidance to consumers and healthcare professionals regarding the use of smart rings. According to the agency's statement, these devices should not be used as tools to diagnose diseases.
Smart rings are wearables that monitor various health parameters, such as heart rate, body temperature, sleep quality, and physical activity levels. Although they have the ability to collect biometric data, ANVISA clarifies that this information does not constitute a medical diagnosis.
The guidance emerges in the context of growing adoption of wearable devices by the population, often with unrealistic expectations about their functionalities. Disease diagnosis requires complete clinical analysis, performed by a qualified professional, supported by validated laboratory tests and scientifically proven methodologies.
ANVISA reinforces that smart rings are devices for monitoring wellness and physical activity, not substitutes for formal medical evaluations. Data collected by these devices may serve as complementary information in health monitoring, but never as an isolated basis for diagnosis.
The agency recommends that users of smart rings seek professional guidance whenever they detect anomalies in monitored parameters. Healthcare professionals are instructed not to consider wearable data as diagnostic evidence without appropriate validation and confirmation through recognized methods.
This guidance reflects ANVISA's commitment to protecting public health and ensuring the appropriate use of monitoring technologies, clearly differentiating wellness devices from diagnostically validated medical equipment.
